- PathKeeper Surgical Celebrates the First Spine Surgery Performed with the PathKeeper 3D Optical Navigation System in Massachusetts
- Yourgene Health Becomes a PacBio Compatible Partner: Enabling PacBio Customers to Optimise Size Selection for Long-Read Sequencing Libraries
- Probo Medical Completes Acquisition of Davis Medical
- Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles
- Cromatic Closes $5.3 Million in Oversubscribed Seed Round to Modernize Life Science R&D Outsourcing
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.
Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future
Ictero Medical Closes $6M Series A Financing
Ictero Medical advises funding will be used to continue product development and complete initial clinical testing.
Ceryx Medical Raises £3.8m In Seed Funding
Funding will be used to commercialize its unique cardiology technology and commence the first-in-human clinical study of the Ceryx Medical innovative cardiac rhythm management device, Cysoni, later this year.
Industry Expert Byline
Reimagining CRM: What’s Next for Medtech Commercial Success | By Akshay Kapadia, CEO and Founder, Conexus Solutions, Inc.
Success depends on more than just choosing the right CRM platform; it requires aligning that platform with optimized business processes, a clear data strategy, and long-term commercial goals. When all of these elements work together, the CRM platform becomes a powerful tool to support growth, innovation, and sustained value.
Signum Surgical Completes Clinical Trial for BioHealx
Moshe Zilversmit, Co-Founder and CEO of Signum Surgical, commented: “The completion of our clinical trial marks a significant milestone for Signum Surgical and our BioHealxTM device. We look forward to submitting our De Novo classification request to the U.S. FDA and the scientific publication of the data in due course, as we seek to bring this novel treatment to market for the benefit of patients, surgeons, and the healthcare system.”
Chung-Ang University Researchers Develop Novel DNA Biosensor for Early Diagnosis of Cervical Cancer
Associate Professor Eunah Kang and Mr. Youngjun Kim from the School of Chemical Engineering and Material Science at Chung-Ang University, Korea have recently come up with an elegant solution. The duo has developed an electrochemical DNA biosensor using a graphitic nano-onion/molybdenum disulfide (MoS2) nanosheet composite, which effectively detects human papillomavirus (HPV)-16 and HPV-18, and can serve as an early diagnosis of cervical cancer.
Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
January 8,2021 Celularity Inc. is a clinical-stage biotechnology company, and leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived
Merck Acquires AmpTec – Adds to Merck’s Lipid Manufacturing Expertise, Providing an Integrated Offering Across mRNA Value Chain
“The success of mRNA-based vaccines for Covid-19 lays the path to accelerate the development of these therapeutics for many other diseases,” said Stefan Oschmann, Chairman of the Executive Board and CEO of Merck.
FDA Medical Device Updates
Our Experts - Byline Articles
Medical Imaging Technologies and Their Impact on Modern Healthcare
Healing Headlines, Transforming Lives: Hospitals in the News
Ewellix Demos Set of New Products for the X-ray Suite
Ewellix noted the new products include lifting columns and sophisticated control units based on the company’s innovative SmartX digital technology.
